BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6752833)

  • 21. Crossreaction of monoclonal anti-T-cell antibodies: implications for classifying B-cell leukemias.
    Munker R; Thiel E; Kummer U; Rodt H; Thierfelder S
    Blut; 1983 Feb; 46(2):95-100. PubMed ID: 6600407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [T- and B-lymphocytes in lymphoproliferative diseases].
    Tsveibakh AS; Gol'dman EI
    Vopr Onkol; 1978; 24(1):11-6. PubMed ID: 305684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological characterization of lymphoproliferative disorders by membrane markers.
    Huber H; Michlmayr G; Huber C; Falkensammer M
    Klin Wochenschr; 1976 Aug; 54(15):699-708. PubMed ID: 790006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias.
    Lukes RJ; Taylor CR; Parker JW; Lincoln TL; Pattengale PK; Tindle BH
    Am J Pathol; 1978 Feb; 90(2):461-86. PubMed ID: 304674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surface receptors of human neoplastic lymphoreticular cells.
    Braylan RC; Jaffe ES; Mann RB; Frank MM; Berard CW
    Haematol Blood Transfus; 1977; 20():47-53. PubMed ID: 344164
    [No Abstract]   [Full Text] [Related]  

  • 26. [Surface markers of human lymphocyte subpopulations, their biological significance and a study of states of immunological deficits and lymphoproliferative disorders].
    Gupta S; Good RA
    Pol Arch Med Wewn; 1977 Feb; 57(2):149-72. PubMed ID: 403513
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical lymphocyte markers: interpretation and indications].
    Preud'homme JL
    Presse Med; 1985 Mar; 14(12):669-71. PubMed ID: 3157960
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunofluorometric analyses of membrane bound IgM in individual human lymphoid cells in cases of leukemia and malignant lymphoma.
    Killander D; Johansson B; Haglund S
    Haematol Blood Transfus; 1977; 20():147-56. PubMed ID: 273002
    [No Abstract]   [Full Text] [Related]  

  • 29. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
    Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
    Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical relevance of lymphocyte surface markers in leukemia and lymphoma.
    Bloomfield CD; Gajl-Peczalska KJ
    Curr Top Hematol; 1980; 3():175-240. PubMed ID: 6276102
    [No Abstract]   [Full Text] [Related]  

  • 31. Lymphocyte surface marker techniques in the routine pathology laboratory.
    Ridway JC; Quinn J; Cardwell M; Flanagan NG
    Med Lab Sci; 1984 Jul; 41(3):246-55. PubMed ID: 6332969
    [No Abstract]   [Full Text] [Related]  

  • 32. A novel human T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas.
    Kamoun M; Kadin ME; Martin PJ; Nettleton J; Hansen JA
    J Immunol; 1981 Sep; 127(3):987-91. PubMed ID: 6790625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant lymphoma with dual B and T cell markers. Analysis of the neoplastic cells with monoclonal antibodies directed against T cell subsets.
    Aisenberg AC; Bloch KJ; Wilkes BM
    J Exp Med; 1981 Nov; 154(5):1709-14. PubMed ID: 6975352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Determination of leukemic B-lymphoma cells with the monoclonal antibody anti-Y 29/55].
    Obrecht JP; Gudat F; Forster HK; Albrecht R; Girard MF; Ludwig C; Christen C
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1529-31. PubMed ID: 6975994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocyte surface markers.
    Thomson AW
    Scott Med J; 1979 Apr; 24(2):118-20. PubMed ID: 315100
    [No Abstract]   [Full Text] [Related]  

  • 36. Monoclonal immunoglobulins and B cell lymphoproliferative disorders.
    Sugai S; Takiguchi T; Konda S
    Nihon Ketsueki Gakkai Zasshi; 1984 Dec; 47(8):1604-15. PubMed ID: 6335808
    [No Abstract]   [Full Text] [Related]  

  • 37. Cell surface phenotype in lymphoproliferative disease.
    Aisenberg AC; Wilkes BM; Long JC; Harris NL
    Am J Med; 1980 Feb; 68(2):206-13. PubMed ID: 6965562
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunological classification of lymphoma and lymphocytic leukemias (author's transl)].
    Derre M; Tubiana N; Carcassonne Y
    Sem Hop; 1980 Dec 18-25; 56(47-68):1999-2003. PubMed ID: 6256913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface markers in leukemias and lymphomas.
    Siegal FP; Filippa DA; Koziner B
    Am J Pathol; 1978 Feb; 90(2):451-60. PubMed ID: 304673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of a combined rosette-fluorescent test in studies on leukemia cells.
    Stella-Hołowiecka B; Hołowiecki J; Szeruda-Rudzka E; Krawczyk-Kuliś M
    Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):165-70. PubMed ID: 375866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.